Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6901 AL 6915

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases

Teixeira MI, Lopes CM, Amaral MH, Costa PC.

Colloids Surf B Biointerfaces. 2023 Jan;221:112999. doi: 10.1016/j.colsurfb.2022.112999. Epub 2022 Nov 2.

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp KO, Glotfelty EJ, Li Y, Greig NH.

Pharmacol Res. 2022 Dec;186:106550. doi: 10.1016/j.phrs.2022.106550. Epub 2022 Nov 11.

Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease

Anand S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, Anwar Khan A, Elderdery AY.

Neuroscience. 2022 Dec 15;507:139-148. doi: 10.1016/j.neuroscience.2022.11.001. Epub 2022 Nov 11.

[Role of β2-Adrenergic Receptor Agonist in the Cognitive Impairment Associated with Neurodegenerative Diseases]

Wang ZJ, Guo WN, Guo QZ, Wang S, Wang TJ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Dec;44(6):1112-1116. doi: 10.3881/j.issn.1000-503X.14469.

Applications of nanobodies in brain diseases

Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G.

Front Immunol. 2022 Nov 8;13:978513. doi: 10.3389/fimmu.2022.978513. eCollection 2022.

Introduction: Unraveling the complex contributions of indigenous microbes to neurological health and disease

Sampson TR.

Int Rev Neurobiol. 2022;167:xi-xvi. doi: 10.1016/S0074-7742(22)00138-6.

Regenerative medicine improve neurodegenerative diseases

Ashraf SS, Hosseinpour Sarmadi V, Larijani G, Naderi Garahgheshlagh S, Ramezani S, Moghadamifar S, Mohebi SL, Brouki Milan P, Haramshahi SMA, Ahmadirad N, Amini N.

Cell Tissue Bank. 2023 Sep;24(3):639-650. doi: 10.1007/s10561-022-10062-0. Epub 2022 Dec 17.

Molecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders

Wu C, Zou P, Feng S, Zhu L, Li F, Liu TC, Duan R, Yang L.

Mol Neurobiol. 2023 Apr;60(4):1749-1765. doi: 10.1007/s12035-022-03175-w. Epub 2022 Dec 26.

Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease

Owoyele PV, Malekzadeh S.

Niger J Physiol Sci. 2022 Dec 31;37(2):157-164. doi: 10.54548/njps.v37i2.1.

Insights into the Mechanism of the Therapeutic Potential of Herbal Monoamine Oxidase Inhibitors in Neurological Diseases

Mannan A, Singh TG, Singh V, Garg N, Kaur A, Singh M.

Curr Drug Targets. 2022;23(3):286-310. doi: 10.2174/1389450122666210707120256.

Structural Plasticity of the Hippocampus in Neurodegenerative Diseases

Weerasinghe-Mudiyanselage PDE, Ang MJ, Kang S, Kim JS, Moon C.

Int J Mol Sci. 2022 Mar 20;23(6):3349. doi: 10.3390/ijms23063349.

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges

Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA.

Cell Mol Life Sci. 2022 Apr 2;79(4):219. doi: 10.1007/s00018-022-04225-1.

Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases

Liu W, Wang G, Wang Z, Wang G, Huang J, Liu B.

Drug Discov Today. 2022 Jul;27(7):1994-2007. doi: 10.1016/j.drudis.2022.04.003. Epub 2022 Apr 6.

Genistein: A focus on several neurodegenerative diseases

Li R, Robinson M, Ding X, Geetha T, Al-Nakkash L, Broderick TL, Babu JR.

J Food Biochem. 2022 Jul;46(7):e14155. doi: 10.1111/jfbc.14155. Epub 2022 Apr 22.

Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review

Klose J, Griehl C, Roßner S, Schilling S.

Biomolecules. 2022 May 12;12(5):694. doi: 10.3390/biom12050694.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias